TOKYO--(BUSINESS WIRE)--The Taiyo Fund announced today that it has significantly increased its position in Miraca Holding Inc. (4544) to over 10% and is the company’s largest shareholder. Miraca Holding, which was formed in July 2005 through a merger between Fujirebio and SRL, is Japan’s leading life science company providing diagnostic and clinical laboratory testing services. The Taiyo Fund is known for its cooperative investment style working with senior management to enhance shareholder value.
